FibroBiologics
FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells.
About FibroBiologics
Based in Houston, Texas, FibroBiologics is a regenerative medicine company developing an innovative solution for chronic disease treatment using fibroblast cells. Currently, FibroBiologics holds 150+ U.S. and International issued patents/patents pending across a variety of clinical pathways, including Disc Degeneration, Orthopedics, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.
Company Facts
- Headquarters
- Houston
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00011_00050
- Funding Stage
- ipo
- Total Funding
- $145,224,987
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-03-31
- Website
- fibrobiologics.com
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/fibrobiologics-24008 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.